Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-013543
Filing Date
2025-04-29
Accepted
2025-04-29 16:26:36
Documents
22
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A crvo20250425_def14a.htm   iXBRL DEF 14A 820424
6 capvni.jpg GRAPHIC 24596
7 capvtsr.jpg GRAPHIC 26661
8 image1.jpg GRAPHIC 232612
9 image2.jpg GRAPHIC 187445
10 logo.jpg GRAPHIC 8537
11 mini.jpg GRAPHIC 5389
  Complete submission text file 0001437749-25-013543.txt   2673817

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crvo-20241231.xsd EX-101.SCH 4593
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20241231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20241231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20241231_pre.xml EX-101.PRE 714
25 EXTRACTED XBRL INSTANCE DOCUMENT crvo20250425_def14a_htm.xml XML 94362
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 25888113
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)